Clinical Trials Update: April 26, 2006

Healthy Patient Studies Hepatitis Diabetes - Type 2

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Healthy Patient Studies

Are you a healthy man or woman, age 30 to 80 who is of Caucasian, Japanese or Chinese (first generation) heritage? If so, you may qualify to participate in a clinical research study testing an investigational medication. To qualify, you must be available for a five-day clinic stay, then three outpatient visits over a two-week period. Qualified participants will receive study-related care and investigational medication at no cost and may receive compensation up to $1450 for time and travel.

The research site is in San Diego, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Hepatitis

This study will evaluate the combination of an investigational drug and an approved drug for treatment of hepatitis C. Volunteers 18 to 64 who have been diagnosed with hepatitis C for at least six months and have not been treated for the disease may qualify. Female participants must be postmenopausal or surgically sterile for at least one year.

The research site is in Gainesville, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat79.html.

-----

Diabetes - Type 2

If you are 18 to 79, and have had no or limited exposure to either oral antidiabetic medication or insulin, you may be eligible to participate in a clinical trial researching an investigational medication for type 2 diabetes. Study participants may receive study-related medical care, study medication, laboratory work and evaluations, glucose monitoring supplies, and diabetic and nutritional counseling, all at no cost.

The research site is in Salt Lake City, Utah.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Copyright 2006 CenterWatch. All rights reserved.

Consumer News